KEYS vs SPRO · P/E 57, rev $4.98B vs P/E 9.6, rev $48.0M
Keysight Technologies Inc (KEYS) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the KEYS and SPRO stock pages for the full models.
Not investment advice.